This brief is an abridged version of the research report “Pharmaceutical manufacturing in Africa: Towards a Research Agenda on Competitiveness and Social Inclusion.” It highlights key research issues as identified through a series of interviews with stakeholders in policy domains, private sector, civil society, industry associations, development partners and research organizations. Inclusion comprises dimensions of: 1) Affordability, including procurement and pricing; 2) Access, related to distribution and supply chains; and 3) Quality, as it relates to standards, counterfeits and pharmaco-vigilance. Innovation, institutions and policies are cross-cutting themes that apply to factors on both the ‘competitiveness’ and ‘inclusion’ arms of the...
It is the inalienable right of the pharmaceutical industry to continue to create medical breakthroug...
The policy brief identifies the barriers to local medicine production in East and Southern Africa (E...
A major target of Goal 3 of the Sustainable Development Goals adopted by the United Nations in 2015 ...
This brief draws on country studies from around the world to illustrate how the pharmaceutical indus...
The study reviews and details the pharmaceutical sector in West Africa. It proposes interventions th...
This book is open access under a CC-BY license. The importance of the pharmaceutical industry in Sub...
This policy brief focuses on the issue of inadequate human resources that can support growth in the ...
Limited access to essential medicines undermines the health systems’ objectives of equity, efficienc...
This chapter discusses standards, an elusive term and concept. For the African pharmaceutical sector...
This final technical report provides a review of the activities, achievements, and challenges of the...
Growing burden of communicable and non-communicable diseases in sub-Saharan Africa has necessitated ...
Despite the global progress made in improving health of people and increasing the life expectancy, S...
ABSTRACT Introduction Limited access to essential medicines undermines the health systems’ objective...
As Chapter 1 briefly outlined, Kenya has a strong and long-standing pharmaceutical industry. A 2015 ...
COVID19 emphasized the already existing vulnerability of Africa's pharmaceutical industry, mainly du...
It is the inalienable right of the pharmaceutical industry to continue to create medical breakthroug...
The policy brief identifies the barriers to local medicine production in East and Southern Africa (E...
A major target of Goal 3 of the Sustainable Development Goals adopted by the United Nations in 2015 ...
This brief draws on country studies from around the world to illustrate how the pharmaceutical indus...
The study reviews and details the pharmaceutical sector in West Africa. It proposes interventions th...
This book is open access under a CC-BY license. The importance of the pharmaceutical industry in Sub...
This policy brief focuses on the issue of inadequate human resources that can support growth in the ...
Limited access to essential medicines undermines the health systems’ objectives of equity, efficienc...
This chapter discusses standards, an elusive term and concept. For the African pharmaceutical sector...
This final technical report provides a review of the activities, achievements, and challenges of the...
Growing burden of communicable and non-communicable diseases in sub-Saharan Africa has necessitated ...
Despite the global progress made in improving health of people and increasing the life expectancy, S...
ABSTRACT Introduction Limited access to essential medicines undermines the health systems’ objective...
As Chapter 1 briefly outlined, Kenya has a strong and long-standing pharmaceutical industry. A 2015 ...
COVID19 emphasized the already existing vulnerability of Africa's pharmaceutical industry, mainly du...
It is the inalienable right of the pharmaceutical industry to continue to create medical breakthroug...
The policy brief identifies the barriers to local medicine production in East and Southern Africa (E...
A major target of Goal 3 of the Sustainable Development Goals adopted by the United Nations in 2015 ...